Advanced in Virilizing Ovarian Tumor

Dr. Mark H. Einstein

Obstetrics and Gynecology | Gynecologic Oncology | Oncology
Montefiore Medical Center
111 E 210th St, 
Bronx, NY 
Accepting New Patients
Advanced in Virilizing Ovarian Tumor
Montefiore Medical Center
111 E 210th St, 
Bronx, NY 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Mark Einstein is an Obstetrics and Gynecologist and a Gynecologic Oncologist in Bronx, New York. Dr. Einstein is rated as an Advanced provider by MediFind in the treatment of Virilizing Ovarian Tumor. His top areas of expertise are Cervical Dysplasia, Cervical Cancer, Human Papillomavirus Infection, Hysterectomy, and Endoscopy. Dr. Einstein is currently accepting new patients.

His clinical research consists of co-authoring 130 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Obstetrics and Gynecology
Gynecologic Oncology
Oncology
Licenses
Obstetrics & Gynecology in NJ
Hospital Affiliations
Montefiore Medical Center
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health First
  • HMO
  • POS
Horizon Healthcare
  • EPO
  • POS
Independent Health
  • EPO
  • POS
  • PPO
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 3 Less Insurance Carriers -

Locations

MONTEFIORE MEDICAL CENTER
111 E 210th St, Bronx, NY 10467

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

ANCHOR Study: Anal Cancer/HSIL Outcomes Research Study
ANCHOR Study: Anal Cancer/HSIL Outcomes Research Study
Enrollment Status: Completed
Publish Date: July 26, 2024
Intervention Type: Drug, Device, Other
Study Drugs: Imiquimod, 5-Fluorouracil
Study Phase: Phase 3
A Randomized Double-Blind, Placebo-controlled Phase II Trial With Safety Run-In of Intramuscular pNGVL4a-Sig/E7(Detox)/HSP70 and TA-CIN for the Treatment of Patients With HPV16+ Atypical Squamous Cells of Undetermined Significance (ASC-US) or Cannot Exclude High Grade SIL (ASC-H) Cytology or Low-grade Squamous Intraepithelial Lesion (LSIL)
A Randomized Double-Blind, Placebo-controlled Phase II Trial With Safety Run-In of Intramuscular pNGVL4a-Sig/E7(Detox)/HSP70 and TA-CIN for the Treatment of Patients With HPV16+ Atypical Squamous Cells of Undetermined Significance (ASC-US) or Cannot Exclude High Grade SIL (ASC-H) Cytology or Low-grade Squamous Intraepithelial Lesion (LSIL)
Enrollment Status: Terminated
Publish Date: June 17, 2024
Intervention Type: Biological, Other
Study Drug: PVX-2
Study Phase: Phase 2
A Phase 2, Randomized, Open Label, Efficacy Study of VGX-3100 Delivered Intramuscularly Followed by Electroporation With CELLECTRA™ 2000 Alone or in Combination With Imiquimod, for the Treatment of HPV-16 and/or HPV-18 Related High Grade Squamous Intraepithelial Lesion (HSIL) of the Vulva
A Phase 2, Randomized, Open Label, Efficacy Study of VGX-3100 Delivered Intramuscularly Followed by Electroporation With CELLECTRA™ 2000 Alone or in Combination With Imiquimod, for the Treatment of HPV-16 and/or HPV-18 Related High Grade Squamous Intraepithelial Lesion (HSIL) of the Vulva
Enrollment Status: Completed
Publish Date: August 25, 2023
Intervention Type: Biological, Drug, Device
Study Drugs: VGX-3100, Imiquimod Cream
Study Phase: Phase 2
A Prospective, Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of VGX-3100 Delivered Intramuscularly Followed by Electroporation With CELLECTRA™-5PSP for the Treatment of HPV-16 and/or HPV-18 Related High Grade Squamous Intraepithelial Lesion (HSIL) of the Cervix
A Prospective, Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of VGX-3100 Delivered Intramuscularly Followed by Electroporation With CELLECTRA™-5PSP for the Treatment of HPV-16 and/or HPV-18 Related High Grade Squamous Intraepithelial Lesion (HSIL) of the Cervix
Enrollment Status: Completed
Publish Date: July 27, 2023
Intervention Type: Biological, Device
Study Drug: VGX-3100
Study Phase: Phase 3
A Randomized, Controlled, Double-Arm, Double-Blind, Multi-Center Study of Ofranergene Obadenovec (VB-111) Combined With Paclitaxel vs. Paclitaxel Combined With Placebo for the Treatment of Recurrent Platinum-Resistant Ovarian Cancer
A Randomized, Controlled, Double-Arm, Double-Blind, Multi-Center Study of Ofranergene Obadenovec (VB-111) Combined With Paclitaxel vs. Paclitaxel Combined With Placebo for the Treatment of Recurrent Platinum-Resistant Ovarian Cancer
Enrollment Status: Completed
Publish Date: January 10, 2023
Intervention Type: Drug
Study Drugs: VB-111, Paclitaxel
Study Phase: Phase 3
Expanded Phase II Trial of a Carrageenan-Containing Gel for Prevention of HPV Infection
Expanded Phase II Trial of a Carrageenan-Containing Gel for Prevention of HPV Infection
Enrollment Status: Withdrawn
Publish Date: August 01, 2019
Intervention Type: Drug, Other
Study Phase: Phase 2
View 5 Less Clinical Trials

130 Total Publications

The Future of Cervical Cancer Screening Is Now.
The Future of Cervical Cancer Screening Is Now.
Journal: Obstetrics and gynecology
Published: September 09, 2025
Similar Doctors
Distinguished in Virilizing Ovarian Tumor
Dr. Dennis S. Chi
Gynecologic Oncology | Oncology | General Surgery
Distinguished in Virilizing Ovarian Tumor
Dr. Dennis S. Chi
Gynecologic Oncology | Oncology | General Surgery

Mskcc Surgery Group

1275 York Ave, 
New York, NY 
 (9.0 miles away)
212-639-2000
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Dennis Chi is a Gynecologic Oncologist and an Oncologist in New York, New York. Dr. Chi is rated as an Elite provider by MediFind in the treatment of Virilizing Ovarian Tumor. His top areas of expertise are Ovarian Cancer, Endometrial Cancer, Ovarian Carcinosarcoma, Oophorectomy, and Salpingo-Oophorectomy. Dr. Chi is currently accepting new patients.

Distinguished in Virilizing Ovarian Tumor
Dr. Oliver Zivanovic
Gynecologic Oncology | Oncology
Distinguished in Virilizing Ovarian Tumor
Dr. Oliver Zivanovic
Gynecologic Oncology | Oncology
1275 York Ave, 
New York, NY 
 (9.0 miles away)
212-639-7033
Languages Spoken:
English
See accepted insurances

Oliver Zivanovic is a Gynecologic Oncologist and an Oncologist in New York, New York. Dr. Zivanovic is rated as an Elite provider by MediFind in the treatment of Virilizing Ovarian Tumor. His top areas of expertise are Ovarian Cancer, Endometrial Cancer, Ovarian Carcinosarcoma, Hysterectomy, and Lymphadenectomy.

Distinguished in Virilizing Ovarian Tumor
Dr. Andrew W. Menzin
Gynecologic Oncology | Oncology | Obstetrics and Gynecology
Distinguished in Virilizing Ovarian Tumor
Dr. Andrew W. Menzin
Gynecologic Oncology | Oncology | Obstetrics and Gynecology

North Shore-Lij Medical PC

27005 76th Ave, 
New Hyde Park, NY 
 (12.6 miles away)
718-470-7000
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Andrew Menzin is a Gynecologic Oncologist and an Oncologist in New Hyde Park, New York. Dr. Menzin is rated as a Distinguished provider by MediFind in the treatment of Virilizing Ovarian Tumor. His top areas of expertise are Ovarian Cancer, Endometrial Cancer, Ovarian Carcinosarcoma, Hernia Surgery, and Oophorectomy.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Einstein's expertise for a condition
ConditionClose
    View All 8 Advanced Conditions
    View All 9 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile